HIGHLIGHTS
- who: K. Pomej from the Division of Gastroenterology and Hepatology, Department of Internal Medicine III, Medical University of Vienna, ViennaAustria have published the paper: Clinical characteristics and outcome of patients with combined hepatocellular-cholangiocarcinoma-a European multicenter cohort, in the Journal: (JOURNAL)
- how: When comparing sorafenib with cytotoxic CHT the results are partly in line with data from the United_States Japan6 Korea8 and France .
SUMMARY
Primary liver cancer is the sixth most common malignant tumor and the third most common cause of cancer-related death globally. Platinum-based chemotherapy (CHT) and . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.